Test of MTX228 for type 1 diabetes with some insulin
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new medication, MTX228, to see if it can help people with type 1 diabetes who still make some insulin. It may slow the loss of your own insulin production and improve blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes that was diagnosed before age 35, or if diagnosed after 35, you have a positive antibody test.
- Your A1c (average blood sugar over 3 months) is between 6.0% and 10.0%.
- You have had diabetes for at least 1 year.
- Your body still makes some insulin (C-peptide level at least 0.3 ng/mL).
- Your BMI is 35 or less, and your kidney function (eGFR) is above 45.
- You are willing to wear a continuous glucose monitor and share the data.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment called GNTI-122 for adults recently diagnosed with type 1 diabetes who still make some insulin. It aims to see if the treatment can help protect the cells that produce insulin.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This trial tests a drug that may help your body use insulin better and improve how your cells produce energy. It might lead to better blood sugar control and less insulin needed.
This study looks at how people with type 1 diabetes are currently treated and their overall metabolic health (like blood sugar control). By participating, you'll help doctors understand what treatments work best and identify areas for improvement.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.